生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | PRT062607 (P505-15) is a novel, highly specific, and potent orally available small-molecule inhibitor of Syk. A FRET assay demonstrates a half-maximal inhibition concentration for Syk at 6±0.2 nM, with a similar inhibitory capacity observed in a radioactive enzyme test, showing a Syk IC50 of 2.1±0.4 nM. In human whole blood, PRT062607 effectively blocks B cell antigen receptor-driven B cell signaling and activation (with IC50 values of 0.27 and 0.28 μM, respectively) and inhibits Fcε receptor 1-triggered basophil degranulation (IC50 of 0.15 μM)[1]. |
细胞研究 | |||||
---|---|---|---|---|---|
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
C57BL/6 mouse bone marrow cells | Cytotoxic assay | 5 h | Cytotoxicity against C57BL/6 mouse bone marrow cells assessed as growth inhibition preincubated for 4 days followed by [3H]-thymidine addition measured after 5 hrs by betaplate counting analysis, IC50=5.853 μM | 25633741 | |
CHO cells | Function assay | Inhibition of human ERG expressed in CHO cells by automated Qpatch clamp assay, IC50=8.6 μM | 25633741 | ||
human Ramos cells | Function assay | Inhibition of SYK in human Ramos cells, IC50=0.223 μM | 23350847 |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.33mL 0.47mL 0.23mL |
11.63mL 2.33mL 1.16mL |
23.26mL 4.65mL 2.33mL |
参考文献 |
---|